Axcella Health Inc. logo

Axcella Health Inc.

NASDAQ:AXLA

Overview | Financials
Company Name Axcella Health Inc.
Symbol AXLA
Currency USD
Price 4.58
Market Cap 0
Dividend Yield 0%
52-week-range 4.58 - 4.58
Industry Biotechnology
Sector Healthcare
CEO Mr. William R. Hinshaw Jr.
Website https://www.axcellahealth.com

An error occurred while fetching data.

About Axcella Health Inc.

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence;

Related Stocks

iCAD, Inc. logo

iCAD, Inc.

ICAD

1.78 USD

Aptose Biosciences Inc. logo

Aptose Biosciences Inc.

APTO

0.25 USD

DURECT Corporation logo

DURECT Corporation

DRRX

0.97 USD

Ardelyx, Inc. logo

Ardelyx, Inc.

ARDX

4.64 USD

Aeglea BioTherapeutics, Inc. logo

Aeglea BioTherapeutics, Inc.

AGLE

12.01 USD

LAVA Therapeutics N.V. logo

LAVA Therapeutics N.V.

LVTX

0.975 USD

Trevi Therapeutics, Inc. logo

Trevi Therapeutics, Inc.

TRVI

4 USD

Financials

Numbers are in millions USD

Numbers are in millions USD